Publicacións (541) Publicacións de Agustín Albillos Martínez Ver datos de investigación referenciados.

2025

  1. Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients

    Liver International, Vol. 45, Núm. 1

  2. Portal hypertension: recommendations for diagnosis and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Centre for Liver and Digestive Diseases (CIBERehd)

    Gastroenterologia y Hepatologia, Vol. 48, Núm. 1

  3. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome

    Journal of Hepatology, Vol. 82, Núm. 1, pp. 72-83

  4. Progressive systemic inflammation precedes decompensation in compensated cirrhosis

    JHEP Reports, Vol. 7, Núm. 2

2024

  1. Autophagy in Its (Proper) Context: Molecular Basis, Biological Relevance, Pharmacological Modulation, and Lifestyle Medicine

    International Journal of Biological Sciences, Vol. 20, Núm. 7, pp. 2532-2554

  2. Beaver tail liver

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 8, pp. 873-875

  3. Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure

    Digestive and Liver Disease, Vol. 56, Núm. 10, pp. 1721-1729

  4. Clinical outcomes of anti-reflux mucosal ablation for gastroesophageal reflux disease: An international bi-institutional study

    Journal of Gastroenterology and Hepatology (Australia), Vol. 39, Núm. 1, pp. 149-156

  5. Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis

    Gut, Vol. 73, Núm. 7, pp. 1183-1198

  6. Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU

    Therapeutic Advances in Gastroenterology, Vol. 17

  7. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis

    JHEP Reports, Vol. 6, Núm. 2

  8. Evolving portal hypertension through Baveno VII recommendations

    Annals of Hepatology, Vol. 29, Núm. 1

  9. Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial

    Journal of Hepatology

  10. Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements

    Hepatology, Vol. 79, Núm. 4, pp. 869-881

  11. Harnessing the Anti-Inflammatory Properties of Polyphenols in the Treatment of Inflammatory Bowel Disease

    International Journal of Biological Sciences, Vol. 20, Núm. 14, pp. 5608-5672

  12. Hepatic cystadenoma as cause of secondary Budd-Chiari syndrome

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 2, pp. 179-180

  13. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

    Journal of Hepatology, Vol. 81, Núm. 5, pp. 827-836

  14. Improving understanding of ferroptosis: Molecular mechanisms, connection with cellular senescence and implications for aging

    Heliyon, Vol. 10, Núm. 21

  15. La especialidad de aparato digestivo: historia, desarrollo nacional y competencias del especialista, perspectiva futura

    RIECS: Revista de Investigación y Educación en Ciencias de la Salud, Vol. 9, Núm. 1, pp. 16-24

  16. Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice

    Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 12, pp. 1604-1615